Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1999-11-30
pubmed:abstractText
Sézary syndrome (SS) is characterized by a malignant proliferation of CD4+ve T cells, which may result in a degree of immunoparesis. Immunosuppression is associated with an increased incidence of internal malignant neoplasms and a high rate of nonmelanoma skin cancer, particularly squamous cell carcinoma. Therefore, we reviewed the incidence of secondary malignant neoplasms in patients with SS.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0003-987X
pubmed:author
pubmed:issnType
Print
pubmed:volume
135
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1381-5
pubmed:dateRevised
2008-3-17
pubmed:meshHeading
pubmed-meshheading:10566838-Adult, pubmed-meshheading:10566838-Aged, pubmed-meshheading:10566838-Aged, 80 and over, pubmed-meshheading:10566838-Antigens, CD4, pubmed-meshheading:10566838-CD4-Positive T-Lymphocytes, pubmed-meshheading:10566838-Carcinoma, Squamous Cell, pubmed-meshheading:10566838-Case-Control Studies, pubmed-meshheading:10566838-Cell Division, pubmed-meshheading:10566838-Clone Cells, pubmed-meshheading:10566838-Cohort Studies, pubmed-meshheading:10566838-Confidence Intervals, pubmed-meshheading:10566838-Follow-Up Studies, pubmed-meshheading:10566838-Hodgkin Disease, pubmed-meshheading:10566838-Humans, pubmed-meshheading:10566838-Immune Tolerance, pubmed-meshheading:10566838-Immunologic Surveillance, pubmed-meshheading:10566838-Incidence, pubmed-meshheading:10566838-Lymphopenia, pubmed-meshheading:10566838-Middle Aged, pubmed-meshheading:10566838-Mouth Neoplasms, pubmed-meshheading:10566838-Neoplasms, Second Primary, pubmed-meshheading:10566838-Sezary Syndrome, pubmed-meshheading:10566838-Skin Neoplasms
pubmed:year
1999
pubmed:articleTitle
Secondary malignant neoplasms in 71 patients with Sézary syndrome.
pubmed:affiliation
Skin Tumour Unit, St John's Institute of Dermatology, St Thomas' Hospital, London, England. juliascarisbrick@doctors.org.uk
pubmed:publicationType
Journal Article, Comparative Study